Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Healthcare 892 Financials 884 Information Technology 517 Industrials 386 Consumer Discretionary 320 Communication Services 200 Consumer Staples 114 Materials 78 Energy 67 Real Estate 64 Utilities 27

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 471 Pharmaceuticals 159 Healthcare Equipment & Supplies 138 Healthcare Providers & Services 61 Life Sciences Tools & Services 38 Health Care Technology 25
Industry stocks

Biotechnology Stocks on NASDAQ

Compare NASDAQ-listed Biotechnology stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

Protara Therapeutics Inc (TARA)
Fair Value26.6% Upside Undervalued Market Cap125.9 M P/E— Yield0.0% HealthFair
  NASDAQ
Q32 Bio Inc (QTTB)
Fair Value-19.3% Downside Overvalued Analyst348.2% Upside Market Cap263.5 M P/E7.8x Yield0.0% HealthGreat
  NASDAQ Featured in High-Growth Small-Cap Stocks
Regenxbio Inc (RGNX)
Fair Value12.5% Upside Fair Analyst232.6% Upside Market Cap487.2 M P/E— Yield0.0% HealthFair
  NASDAQ
Rein Therapeutics Inc (RNTX)
Fair Value-30.5% Downside Overvalued Analyst880.4% Upside Market Cap52.795 M P/E— Yield0.0% HealthFair
  NASDAQ
Rhythm Pharmaceuticals Inc (RYTM)
Fair Value-15.6% Downside Fair Analyst33.6% Upside Market Cap7.281 B P/E— Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Momentum
Rocket Pharmaceuticals Inc (RCKT)
Fair Value25.6% Upside Undervalued Analyst251.6% Upside Market Cap267.3 M P/E— Yield0.0% HealthFair
  NASDAQ Featured in High-Growth Small-Cap Stocks
Scinai Immunotherapeutics Ltd ADR (SCNI)
Fair Value61.6% Upside Bargain Market Cap262.21 K P/E— Yield0.0% HealthFair
  NASDAQ
Seres Therapeutics Inc (MCRB)
Fair Value40.2% Upside Undervalued Analyst713.4% Upside Market Cap20.994 M P/E— Yield0.0% HealthFair
  NASDAQ
Solid Biosciences LLC (SLDB)
Fair Value-1.9% Downside Fair Analyst202.8% Upside Market Cap662.7 M P/E— Yield0.0% HealthFair
  NASDAQ
Spero Therapeutics Inc (SPRO)
Fair Value27.7% Upside Undervalued Analyst422.9% Upside Market Cap59.4 M P/E8.0x Yield0.0% HealthGreat
  NASDAQ
Spyre Therapeutics Inc (SYRE)
Fair Value-45.0% Downside Overvalued Analyst26.9% Upside Market Cap9.173 B P/E— Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Momentum
Summit Therapeutics PLC (SMMT)
Fair Value-0.1% Downside Fair Analyst114.0% Upside Market Cap11.348 B P/E— Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Momentum Bullish Trend Stocks
Syndax Pharmaceuticals Inc (SNDX)
Fair Value47.4% Upside Undervalued Analyst297.8% Upside Market Cap840 M P/E— Yield0.0% HealthFair
  NASDAQ
UroGen Pharma Ltd (URGN)
Fair Value50.9% Upside Bargain Analyst139.9% Upside Market Cap1.262 B P/E— Yield0.0% HealthFair
  NASDAQ
Viking Therapeutics Inc (VKTX)
Fair Value7.0% Upside Fair Analyst269.6% Upside Market Cap3.289 B P/E— Yield0.0% HealthWeak
  NASDAQ
VistaGen Therapeutics Inc (VTGN)
Fair Value61.8% Upside Bargain Analyst506.1% Upside Market Cap7.398 M P/E— Yield0.0% HealthWeak
  NASDAQ
Voyager Therapeutics Inc (VYGR)
Fair Value32.5% Upside Undervalued Analyst765.6% Upside Market Cap106 M P/E— Yield0.0% HealthWeak
  NASDAQ
VTv Therapeutics Inc (VTVT)
Fair Value27.4% Upside Undervalued Analyst157.6% Upside Market Cap269.9 M P/E— Yield0.0% HealthGood
  NASDAQ Featured in High-Growth Small-Cap Stocks
Whitehawk Therapeutics Inc (WHWK)
Fair Value29.0% Upside Undervalued Analyst155.4% Upside Market Cap172.2 M P/E— Yield0.0% HealthFair
  NASDAQ
X4 Pharmaceuticals Inc (XFOR)
Fair Value5.7% Upside Fair Analyst277.9% Upside Market Cap304.4 M P/E— Yield0.0% HealthFair
  NASDAQ
XBiotech Inc (XBIT)
Fair Value65.8% Upside Bargain Market Cap57.012 M P/E— Yield0.0% HealthFair
  NASDAQ
Xenon Pharmaceuticals Inc (XENE)
Fair Value2.6% Upside Fair Analyst90.4% Upside Market Cap3.649 B P/E— Yield0.0% HealthFair
  NASDAQ
Zai Lab Ltd (ZLAB)
Fair Value-9.4% Downside Fair Analyst48.1% Upside Market Cap2.806 B P/E— Yield0.0% HealthFair
  NASDAQ
Zymeworks Inc (ZYME)
Fair Value11.6% Upside Fair Analyst44.4% Upside Market Cap2.039 B P/E— Yield0.0% HealthFair
  NASDAQ
4D Molecular Therapeutics Inc (FDMT)
Fair Value27.4% Upside Undervalued Analyst149.7% Upside Market Cap621.5 M P/E— Yield0.0% HealthGood
  NASDAQ
Absci Corp (ABSI)
Fair Value-24.2% Downside Overvalued Analyst57.8% Upside Market Cap1.611 B P/E— Yield0.0% HealthFair
  NASDAQ
ABVC Biopharma Inc (ABVC)
Fair Value38.4% Upside Undervalued Market Cap25.216 M P/E— Yield0.0% HealthFair
  NASDAQ
Acumen Pharmaceuticals Inc (ABOS)
Fair Value45.3% Upside Undervalued Analyst367.3% Upside Market Cap15.464 M P/E— Yield0.0% HealthWeak
  NASDAQ
Acurx Pharmaceuticals LLC (ACXP)
Fair Value33.9% Upside Undervalued Market Cap4.984 M P/E— Yield0.0% HealthFair
  NASDAQ
Adagene Inc (ADAG)
Fair Value20.5% Upside Undervalued Analyst390.5% Upside Market Cap135.6 M P/E— Yield0.0% HealthFair
  NASDAQ
Alector Inc (ALEC)
Fair Value-15.2% Downside Fair Analyst86.6% Upside Market Cap309.9 M P/E— Yield0.0% HealthFair
  NASDAQ
Aligos Therapeutics Inc (ALGS)
Fair Value32.4% Upside Undervalued Market Cap28.163 M P/E— Yield0.0% HealthFair
  NASDAQ
Allogene Therapeutics Inc (ALLO)
Fair Value37.4% Upside Undervalued Analyst725.7% Upside Market Cap376.6 M P/E— Yield0.0% HealthFair
  NASDAQ Featured in High-Growth Small-Cap Stocks
Alx Oncology Holdings (ALXO)
Fair Value33.2% Upside Undervalued Analyst300.0% Upside Market Cap159 M P/E— Yield0.0% HealthFair
  NASDAQ
Alzamend Neuro Inc (ALZN)
Fair Value14.9% Upside Fair Market Cap7.48 M P/E— Yield0.0% HealthFair
  NASDAQ
Annexon Inc (ANNX)
Fair Value19.6% Upside Undervalued Analyst324.5% Upside Market Cap759.3 M P/E— Yield0.0% HealthFair
  NASDAQ
Aprea Therapeutics Inc (APRE)
Fair Value33.5% Upside Undervalued Analyst566.7% Upside Market Cap6.236 M P/E— Yield0.0% HealthWeak
  NASDAQ
Aptorum Group Ltd Class A (NIKI)
Fair Value-49.2% Downside Overvalued Market Cap4.408 M P/E— Yield0.0% HealthFair
  NASDAQ
Arcutis Biotherapeutics Inc (ARQT)
Fair Value27.7% Upside Undervalued Analyst44.9% Upside Market Cap3.414 B P/E114.2x Yield0.0% HealthGreat
  NASDAQ
ARS Pharmaceuticals Inc (SPRY)
Fair Value66.3% Upside Bargain Analyst818.2% Upside Market Cap263.5 M P/E— Yield0.0% HealthWeak
  NASDAQ
Autolus Therapeutics Ltd (AUTL)
Fair Value43.5% Upside Undervalued Analyst594.4% Upside Market Cap335.4 M P/E— Yield0.0% HealthFair
  NASDAQ
Barinthus Biotherapeutics PLC (BRNS)
Market Cap272.1 M P/E—
  NASDAQ
Beam Therapeutics Inc (BEAM)
Fair Value-9.7% Downside Fair Analyst90.9% Upside Market Cap2.578 B P/E— Yield0.0% HealthFair
  NASDAQ
Bicycle Therapeutics Ltd (BCYC)
Fair Value52.7% Upside Bargain Analyst163.4% Upside Market Cap243.9 M P/E— Yield0.0% HealthFair
  NASDAQ
Bioatla Inc (BCAB)
  NASDAQ
Biocardia Inc (BCDA)
Fair Value-0.5% Downside Fair Market Cap13.474 M P/E— Yield0.0% HealthFair
  NASDAQ
Biomea Fusion Inc (BMEA)
Fair Value22.0% Upside Undervalued Analyst945.2% Upside Market Cap42.577 M P/E— Yield0.0% HealthFair
  NASDAQ
BioNTech SE (BNTX)
Fair Value-0.2% Downside Fair Analyst35.7% Upside Market Cap21.287 B P/E— Yield0.0% HealthFair
  NASDAQ
BioRestorative Therapies Inc (BRTX)
Fair Value46.3% Upside Undervalued Market Cap1.924 M P/E— Yield0.0% HealthWeak
  NASDAQ
Biovie Inc (BIVI)
Fair Value35.1% Upside Undervalued Analyst334.3% Upside Market Cap9.127 M P/E— Yield0.0% HealthFair
  NASDAQ
Explore listed stocks on NASDAQ with company information and fair value data.